ibd and glp 1 GLPs as novel therapeutic options in IBD-potential mechanisms of action If you are living with

Formalised and updated education on the scientific paradigm of diabetes and obesity will help more to understand the pathophysiology of these two diseases

Australias Therapeutic Goods Administration (TGA) has approved semaglutide, dulaglutide and liraglutide for managing type 2 diabetes in adults, while tirzepatide is TGA-approved for the management of both type 2 diabetes and chronic weight management

In addition to insulin-producing islet cells, the somatostatin-producing islet cells also express GLP1R, whereas glucagon-producing cells appear to lack such receptors

Ong LT, Sia CH (2025) Interactions between antidiabetes medications and heart-brain axis

Your provider may also assess whether underlying dehydration, blood pressure changes, or electrolyte imbalances are contributing